Crossover Trial of AD182 and AD504 in Obstructive Sleep Apnea

NCT04645524 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Obstructive Sleep Apnea

Interventions

DRUG: AD182
DRUG: AD504
DRUG: Placebo
DIAGNOSTIC_TEST: Polysomnography

Sponsor

Apnimed